• No results found

[PDF] Top 20 A Study Comparing the Efficacy of Ondansetron, Palenosetron and Aprepitant in the Prevention of Chemotherapy induced Nausea and Vomiting in Breast Cancer patients receiving Moderately Emetogenic Chemotherapy.

Has 10000 "A Study Comparing the Efficacy of Ondansetron, Palenosetron and Aprepitant in the Prevention of Chemotherapy induced Nausea and Vomiting in Breast Cancer patients receiving Moderately Emetogenic Chemotherapy." found on our website. Below are the top 20 most common "A Study Comparing the Efficacy of Ondansetron, Palenosetron and Aprepitant in the Prevention of Chemotherapy induced Nausea and Vomiting in Breast Cancer patients receiving Moderately Emetogenic Chemotherapy.".

A Study Comparing the Efficacy of Ondansetron, Palenosetron and Aprepitant in the Prevention of Chemotherapy induced Nausea and Vomiting in Breast Cancer patients receiving Moderately Emetogenic Chemotherapy.

A Study Comparing the Efficacy of Ondansetron, Palenosetron and Aprepitant in the Prevention of Chemotherapy induced Nausea and Vomiting in Breast Cancer patients receiving Moderately Emetogenic Chemotherapy.

... all patients receiving cisplatin will have nausea and vomiting 1 to 2 hours after receiving ...of chemotherapy; delayed onset (in part substance P related), occurring 24 hours to ... See full document

82

Palonosetron in the prevention of chemotherapy-induced nausea and vomiting: an evidence-based review of safety, efficacy, and place in therapy

Palonosetron in the prevention of chemotherapy-induced nausea and vomiting: an evidence-based review of safety, efficacy, and place in therapy

... with aprepitant. All patients received the same triple combination of palonosetron, dexamethasone, and aprepitant administered on day 1 for prophylaxis of acute ...more patients ... See full document

13

Fosaprepitant and aprepitant: an update of the evidence for their place in the prevention of chemotherapy-induced nausea and vomiting

Fosaprepitant and aprepitant: an update of the evidence for their place in the prevention of chemotherapy-induced nausea and vomiting

... review: Aprepitant in combination with a serotonin antagonist and a corticosteroid con- trols acute and delayed symptoms of CINV in patients receiving moderately to highly emetogenic ... See full document

14

Antiemetic therapy options for chemotherapy-induced nausea and vomiting in breast cancer patients

Antiemetic therapy options for chemotherapy-induced nausea and vomiting in breast cancer patients

... assigned patients to either an aprepitant-containing regimen (triple combination of ondansetron, dexamethasone, and aprepitant in the first 24 hours, followed by aprepitant monotherapy ... See full document

10

Safety, efficacy, and patient acceptability of single-dose fosaprepitant regimen for the prevention of chemotherapy-induced nausea and vomiting

Safety, efficacy, and patient acceptability of single-dose fosaprepitant regimen for the prevention of chemotherapy-induced nausea and vomiting

... oral aprepitant to ondansetron plus dexamethasone increases the proportion of patients achieving complete response (CR; defined as no vomiting and no rescue antiemetics) by 9%–21% dur- ing the ... See full document

10

EFFICACY AND COST OF GRANISETRON VERSUS ONDANSETRON IN THE PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING AMONG CANCER PATIENTS AT KENYATTA NATIONAL HOSPITAL

EFFICACY AND COST OF GRANISETRON VERSUS ONDANSETRON IN THE PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING AMONG CANCER PATIENTS AT KENYATTA NATIONAL HOSPITAL

... of chemotherapy administration), delayed (observed from the second day post chemotherapy administration and may persist for 5 - 7 days) or anticipatory (observed before chemotherapy ...during ... See full document

6

Aprepitant: the evidence for its place in the prevention of chemotherapy-induced nausea and vomiting

Aprepitant: the evidence for its place in the prevention of chemotherapy-induced nausea and vomiting

... With moderately emetogenic chemotherapy, acute CINV can be prevented in up to 90% of patients receiving a corticosteroid, which also reduces the risk of delayed emesis (Gralla et ... See full document

16

Cost-effectiveness of an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer in the UK

Cost-effectiveness of an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer in the UK

... Purpose: Prevention of chemotherapy-induced nausea and vomiting (CINV) remains an impor- tant goal for patients receiving ...this study was to define, from the UK ... See full document

10

Use of granisetron transdermal system in the prevention of chemotherapy-induced nausea and vomiting: a review

Use of granisetron transdermal system in the prevention of chemotherapy-induced nausea and vomiting: a review

... antiemetic efficacy of transdermal granisetron in chemotherapy-induced nausea and vomiting, in patients receiving moderately and highly emetogenic ... See full document

12

Relationship between traditional Chinese medicine constitutional types with chemotherapy induced nausea and vomiting in patients with breast cancer: an observational study

Relationship between traditional Chinese medicine constitutional types with chemotherapy induced nausea and vomiting in patients with breast cancer: an observational study

... with breast cancer upon histological examination of the surgical spe- cimen at The First Hospital of XI’an Jiaotong University, the Shaanxi General Hospital of Chinese Armed Police Force (CAPF), and the ... See full document

9

Comparison of the Efficacy of Ondansetron and Aprepitant for the Prevention of Postoperative Nausea and Vomiting: A Double Blinded Randomized Control Trial in Patients Undergoing Mastectomy/Thyroidectomy

Comparison of the Efficacy of Ondansetron and Aprepitant for the Prevention of Postoperative Nausea and Vomiting: A Double Blinded Randomized Control Trial in Patients Undergoing Mastectomy/Thyroidectomy

... a study done by Taheri et al, found that oral clonidine premedication considerably reduced the incidence of PONV in patients having day care ear surgical ...controlled study by Mubarak et al to ... See full document

121

Chemotherapy-induced nausea and vomiting: exploring patients’ subjective experience

Chemotherapy-induced nausea and vomiting: exploring patients’ subjective experience

... with patients’ daily ...helping patients fulfill their normal duties whilst experiencing this chemotherapy side ...with breast cancer have helped to improve their coping behaviors, ... See full document

7

Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics

Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics

... Abstract: Chemotherapy-induced nausea and vomiting (CINV) is one of the most common symptoms feared by patients, but may be prevented or lessened with appropriate ...the ... See full document

7

The effect of Vitamin B6 on chemotherapy induced nausea and vomiting in pediatric cancer

The effect of Vitamin B6 on chemotherapy induced nausea and vomiting in pediatric cancer

... used chemotherapy agent ...of nausea(R=0.313, P- value=0.0016) and frequency of vomiting with age was found ...of vomiting and different tumor types in this study ...of nausea (P ... See full document

9

Effect of acupuncture in prevention and treatment of chemotherapy induced nausea and vomiting in patients with advanced cancer: study protocol for a randomized controlled trial

Effect of acupuncture in prevention and treatment of chemotherapy induced nausea and vomiting in patients with advanced cancer: study protocol for a randomized controlled trial

... the efficacy of acupuncture in CINV [12, ...controlled study and showed that in patients with breast cancer receiving high-dose chemotherapy, adjunct electroacupuncture ... See full document

8

The effect of massage therapy on chemotherapy-induced nausea and vomiting in pediatric cancer

The effect of massage therapy on chemotherapy-induced nausea and vomiting in pediatric cancer

... This study is a randomized controlled trial in which the effects of massage therapy on nausea and vomiting indices within and during 48 h after chemotherapy were ...pilot study, was 70 ... See full document

5

A review of nabilone in the treatment of chemotherapy-induced nausea and vomiting

A review of nabilone in the treatment of chemotherapy-induced nausea and vomiting

... Anticipatory nausea and vomiting is a learned response to chemotherapy that develops only after poor initial control of ...anticipatory nausea and vom- iting follows the theory of a Pavlovian ... See full document

10

RECENT UPDATES IN THE MANAGEMENT OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING

RECENT UPDATES IN THE MANAGEMENT OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING

... the prevention of delayed CINV, it is not much in use now because of its low therapeutic index and its use is generally reserved for agents with low emetogenic potential or in patients intolerant or ... See full document

6

Coping With Nausea and Vomiting From Chemotherapy

Coping With Nausea and Vomiting From Chemotherapy

... with cancer and their families can take part in support groups in person, online, or on the ...helps patients without prescription coverage get the medicines they need through the public or private program ... See full document

20

Evaluation of Adherence to Chemotherapy Induced Nausea and Vomiting Guidelines  An Observational Study

Evaluation of Adherence to Chemotherapy Induced Nausea and Vomiting Guidelines An Observational Study

... on cancer and cancer sup- portive care are issued and updated frequently by many well recognized associations and ...improving cancer care and ...in Cancer (MASCC) is an international, ... See full document

8

Show all 10000 documents...